Mini-review: overcoming tumor-intrinsic resistance to immune effector function

European Journal of Immunology
Ruth GanssGünter J Hämmerling

Abstract

In immunological cancer therapy, the current treatment emphasis is on the generation of effector cells that are specific for tumor antigens. However, there is a distressing lack of correlation between the induction of specific immunity in cancer patients and measurable clinical benefit. By studying mouse models of de novo tumorigenesis we are beginning to understand that the tumor itself, in particular the manifestation of a distinct tumor environment, impairs immune effector function; this concept is yet to be applied in human malignancy.

Citations

Apr 12, 2013·Archivum Immunologiae Et Therapiae Experimentalis·Agata MatejukClaudine Kieda
Aug 21, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Joseph J SkitzkiSharon S Evans
Aug 29, 2007·Cancer Immunology, Immunotherapy : CII·James A ThompsonSuzanne Ostrand-Rosenberg
Sep 29, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Govardhana Rao YannamLarisa Y Poluektova
Oct 1, 2008·International Immunology·Connie JackamanDelia J Nelson
May 10, 2006·Immunology and Cell Biology·Theo NicholaouJonathan Cebon
Oct 22, 2005·Annals of the Rheumatic Diseases·A LimmerG J Hämmerling
Jul 12, 2011·Physiological Reviews·Shom GoelRakesh K Jain
Apr 10, 2008·The Journal of Clinical Investigation·Juliana HamzahRuth Ganss
Nov 29, 2012·The Journal of Clinical Investigation·Nancy Klauber-Demore
Mar 1, 2007·Blood·Ainhoa Perez-DiezPolly Matzinger
Dec 22, 2010·Genetic Vaccines and Therapy·Sara A CollinsMark Tangney
Oct 31, 2013·Trends in Molecular Medicine·Anna JohanssonRuth Ganss
Dec 24, 2013·International Journal of Breast Cancer·Gisela Bevilacqua Rolfsen Ferreira da SilvaChristiane Pienna Soares
May 9, 2014·Thyroid : Official Journal of the American Thyroid Association·Viswanath GundaSareh Parangi
Jul 30, 2005·Expert Opinion on Biological Therapy·Volker Schirrmacher
Oct 27, 2007·Taiwanese Journal of Obstetrics & Gynecology·Chi-Mou JuangMing-Shien Yen
Jul 28, 2009·European Journal of Immunology·Thomas Kammertoens, Thomas Blankenstein
Aug 10, 2006·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander H EnkGerold Schuler
Mar 14, 2009·Scandinavian Journal of Immunology·B Rubin
Mar 28, 2006·Biochemical and Biophysical Research Communications·Demelza J NeedhamManfred W Beilharz
May 11, 2005·Trends in Molecular Medicine·Thomas KammertoensThomas Blankenstein
May 12, 2005·Current Opinion in Immunology·Pierre G Coulie, Thierry Connerotte
Jul 16, 2013·The Veterinary Journal·Mark A Suckow
Apr 2, 2008·Expert Review of Vaccines·Mark A SuckowElliot D Rosen
Mar 3, 2017·Current Opinion in Oncology·Mark W BallRamaprasad Srinivasan
Jan 1, 2012·Cancers·Anna Johansson, Ruth Ganss
May 12, 2006·Nature·John L LangowskiMartin Oft
Jul 26, 2006·Journal of Leukocyte Biology·Delia Nelson, Ruth Ganss
May 17, 2005·Bone Marrow Transplantation·B W Butcher, R H Collins
Jun 28, 2005·International Journal of Cancer. Journal International Du Cancer·Ingeborg ZehbeMarkus J Maeurer
Jan 25, 2008·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Sharon S EvansQing Chen
Jan 16, 2018·Nature Reviews. Immunology·Yuhui HuangWen Jiang
Jul 26, 2011·Expert Review of Gastroenterology & Hepatology·Sukanya Raghavan, Marianne Quiding-Järbrink
Dec 17, 2019·International Journal of Cancer. Journal International Du Cancer·Xichen ZhengYuhui Huang
Jul 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Reinhold SchirmbeckJörg Reimann
Nov 19, 2020·Nanoscale Horizons : the Home for Rapid Reports of Exceptional Significance in Nanoscience and Nanotechnolgy·Yaxin ZhouYuxia Luan
Aug 1, 2019·Cancer Research·Verra M NgwaJin Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.